Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5498412 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2382161 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL249006 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3051342 | 1.00 | CA4 (0.50) | — | |
| Hydrochloric Acid SCHEMBL4876348 | 1.00 | CA4 (0.50) | — | |
| Hydrochloric Acid SCHEMBL11003423 | 1.00 | CA4 (0.50) | — | |
| Hydrochloric Acid SCHEMBL8378160 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9373462 | 1.00 | CA4 (0.50) | — | |
| Hydrochloric Acid SCHEMBL377646 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1191765 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0812324-B1 | AQUEOUS SPECTINOMYCIN BORATE SOLUTIONS | MERIAL SAS (FR) | 2000-05-10 | — | — | EP | claimed |
| EP-0812324-A1 | AQUEOUS SPECTINOMYCIN BORATE SOLUTIONS | Mérial (FR) | 1997-12-17 | — | — | EP | claimed |
| US-5556879-A | STABILITY AT HIGH CONCENTRATION | RHONE MERIEUX, INC. (US) | 1996-09-17 | — | — | US | claimed |
| WO-1996026945-A1 | AQUEOUS SPECTINOMYCIN BORATE SOLUTIONS | MERIAL (FR) | 1996-09-06 | — | — | WO | claimed |
| US-4312884-A | Treatment of herpes simplex | SOICHET SAMUEL | 1982-01-26 | — | — | US | claimed |
| EP-4626866-A1 | NOVEL TRILACICLIB INTERMEDIATES, METHOD OF PREPARATION AND USE THEREOF | Assia Chemical Industries Ltd. (IL) | 2025-10-08 | — | — | EP | disclosed |
| US-20250144067-A1 | PERSONALIZED STARVATION THERAPY FOR CANCER | FAETH THERAPEUTICS, INC. | 2025-05-08 | — | — | US | disclosed |
| WO-2024116069-A1 | NOVEL TRILACICLIB INTERMEDIATES, METHOD OF PREPARATION AND USE THEREOF | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2024-06-06 | — | — | WO | disclosed |
| US-11779905-B2 | Catalyst compositions and process for direct production of hydrogen cyanide in an acrylonitrile reactor feed stream | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2023-10-10 | — | — | US | disclosed |
| EP-3259366-B1 | MICROBIAL MICROFLUIDIC BIOSENSOR | UNIV CALIFORNIA (US) | 2022-04-20 | — | — | EP | disclosed |
| US-20210146339-A1 | CATALYST COMPOSITIONS AND PROCESS FOR DIRECT PRODUCTION OF HYDROGEN CYANIDE IN AN ACRYLONITRILE REACTOR FEED STREAM | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-20 | — | — | US | disclosed |
| EP-3744418-A1 | CATALYST COMPOSITIONS AND PROCESS FOR DIRECT PRODUCTION OF HYDROGEN CYANIDE IN AN ACRYLONITRILE REACTOR FEED STREAM | Ascend Performance Materials Operations LLC (US) | 2020-12-02 | — | — | EP | disclosed |
| WO-1998025901-A1 | INDOLIN-2-ONE DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANOFI (FR) | 1998-06-18 | — | — | WO | disclosed |
| US-5716965-A | Substituted 3-aminoquinuclidines | PFIZER INC. (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0812324-A1 | AQUEOUS SPECTINOMYCIN BORATE SOLUTIONS | Mérial (FR) | 1997-12-17 | — | — | EP | disclosed |
| US-5556879-A | STABILITY AT HIGH CONCENTRATION | RHONE MERIEUX, INC. (US) | 1996-09-17 | — | — | US | disclosed |
| WO-1996026945-A1 | AQUEOUS SPECTINOMYCIN BORATE SOLUTIONS | MERIAL (FR) | 1996-09-06 | — | — | WO | disclosed |
| EP-0585328-A1 | SUBSTITUTED 3-AMINOQUINUCLIDINES | PFIZER INC. (US) | 1994-03-09 | — | — | EP | disclosed |
| WO-1992020676-A1 | SUBSTITUTED 3-AMINOQUINUCLIDINES | PFIZER INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| US-4312884-A | Treatment of herpes simplex | SOICHET SAMUEL | 1982-01-26 | — | — | US | disclosed |